卢晓博;李星烁;李会阳;王辰;韩姹;武文娟;闫晔;田文艳;王颖梅;薛凤霞;

• 1:天津医科大学总医院妇产科

摘要(Abstract)：

目的:比较口服氟康唑胶囊与口服氟康唑胶囊联合阴道放置硝呋太尔片治疗外阴阴道假丝酵母菌病(VVC)合并需氧菌性阴道炎(AV)混合感染的疗效,探讨VVC合并AV的合适治疗方案。方法:收集2014年1月至2016年11月天津医科大学总医院收治的VVC合并AV患者173例。将患者随机分为两组:89例给予口服氟康唑治疗(单药组),84例给予口服氟康唑胶囊联合阴道放置硝呋太尔片治疗(双药组),统计两组的治愈率、有效率及复发率。结果:173例患者中,91.9%为VVC合并轻、中度AV患者。单、双药组中,VVC合并轻、中度AV患者的治愈率、有效率均高于合并重度AV患者。单、双药组间比较,VVC合并轻、中度AV的治愈率(轻度:76.4%vs 73.5%,中度:77.3%vs 90.5%)、有效率(轻度:94.5%vs 93.9%,中度:95.5%vs 100.0%)差异均无统计学意义(P>0.05)。结论:对于VVC合并轻、中度AV的患者,单纯口服氟康唑可取得氟康唑与硝呋太尔联合用药相同的治疗效果。

关键词(KeyWords)： 外阴阴道假丝酵母菌病;需氧菌性阴道炎;氟康唑胶囊;硝呋太尔片;治疗

Abstract:

Keywords:

基金项目(Foundation): 国家自然科学基金(No:81471419);; 天津市自然科学基金(No:16JCYBJC26400)

作者(Author): 卢晓博;李星烁;李会阳;王辰;韩姹;武文娟;闫晔;田文艳;王颖梅;薛凤霞;

Email:

DOI: 10.13283/j.cnki.xdfckjz.2018.05.001

参考文献(References)：

• [1]Liang Q,Li N,Song S,et al.High-dose nifuratel for simple and mixed aerobic vaginitis:A single-center prospective open-label cohort study[J].J Obstet Gynaecol Res,2016,42(10):1354-1360
• [2]Togni G,Battini V,Bulgheroni A,et al.In vitro activity of nifuratel on vaginal bacteria:could it be a good candidate for the treatment of bacterial vaginosis?[J].Antimicrob Agents Chemother,2011,55(5):2490-2492
• [3]Donders G,Bellen G,Ausma J,et al.The effect of antifungal treatment on the vaginal flora of women with vulvo-vaginal yeast infection with or without bacterial vaginosis[J].Eur J Clin Microbiol Infect Dis,2011,30(1):59-63
• [4]Donders GG,Vereecken A,Bosmans E,et al.Definition of a type of abnormal vaginal flora that is distinct from bacterial vaginosis:aerobic vaginitis[J].BJOG,2002,109(1):34-43
• [5]Fan A,Yue Y,Geng N,et al.Aerobic vaginitis and mixed infections:comparison of clinical and laboratory findings[J].Arch Gynecol Obstet,2013,287(2):329-335
• [6]Wang ZL,Fu LY,Xiong ZA,et al.Diagnosis and microecological characteristics of aerobic vaginitis in outpatients based on preformed enzymes[J].Taiwan J Obstet Gynecol,2016,55(1):40-44
• [7]Liu MB,Xu SR,He Y,et al.Diverse vaginal microbiomes in reproductive-age women with vulvovaginal candidiasis[J].PLo S One,2013,8(11):e79812
• [8]Auger P,Joly J.Microbial flora associated with Candida albicans vulvovaginitis[J].Obstet Gynecol,1980,55(3):397-401
• [9]王辰,范爱萍,薛凤霞.《2015年美国疾病控制和预防中心关于阴道炎症的诊治规范》解读[J].国际妇产科学杂志,2015,42(6):676-679
• [10]Goncalves B,Ferreira C,Alves CT,et al.Vulvovaginal candidiasis:epidemiology,microbiology and risk factors[J].Crit Rev Microbiol,2016,42(6):905-927
• [11]Polatti F,Nappi RE,Brundu B,et al.Clinical study on the dose-effect relationship of a nifuratel-nystatin combination in the treatment of vulvo-vaginal infections[J].Arzneimittelforschung,2003,53(10):730-737
• [12]Cepicky P,Malina J,Libalova Z,et al."Mixed"and"miscellaneous"vulvovaginitis:diagnostics and therapy of vaginal administration of nystatin and nifuratel[J].Ceska Gynekol,2005,70(3):232-237
• [13]Fernandez-Alba J,Valle-Gay A,Dibildox M,et al.Fenticonazole nitrate for treatment of vulvovaginitis:efficacy,safety,and tolerability of 1-gram ovules,administered as ultra-short 2-day regimen[J].J Chemother,2004,16(2):179-186
• [14]Sobel JD,Kapernick PS,Zervos M,et al.Treatment of complicated Candida vaginitis:comparison of single and sequential doses of fluconazole[J].Am J Obstet Gynecol,2001,185(2):363-369
• [15]Muzny CA,Schwebke JR.Biofilms:an underappreciated mechanism of treatment failure and recurrence in vaginal infections:table 1[J].Clin Infect Dis,2015,61(4):601-606